Energy-based therapies for vulvar lichen sclerosus: A systematic review of randomized controlled trials
Maturitas · 2026-08 · 211 · 109039
DOI: 10.1016/j.maturitas.2026.109039 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Maturitas, 2026-08. Verfasst von E Aksahin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Istanbul University Cerrahpasa - Cerrahpasa Faculty of Medicine, Department of Obtsterics and Gynecology, Turkey. Electronic address: elif.aksahin@is…. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Lasers, Gas, Lasers, Solid-State, Low-Level Light Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Vulvar lichen sclerosus (VLS) is a chronic, relapsing dermatosis that significantly impairs quality of life. While topical corticosteroids remain the first-line therapy, recurrence and steroid-related side-effects have prompted interest in alternative options. This systematic review evaluates the efficacy and safety of laser therapies compared with other treatments for VLS. METHODS: A systematic search was performed in MEDLINE (via PubMed), Scopus, Web of Science, CINAHL, and the Cochrane Central Register of Controlled Trials (CENTRAL). Searches used Medical Subject Headings (MeSH) and free-text terms. Randomized controlled trials (RCTs) meeting predefined criteria were included. Two independent reviewers assessed study eligibility and methodological quality using the JBI critical appraisal checklist for RCTs; discrepancies were resolved by a third reviewer. RESULTS: Seven RCTs involving 337 women were included. The majority of studies evaluated fractional CO₂ laser therapy, while others investigated Nd:YAG-based or combination laser modalities. Comparators included sham or low-dose laser, topical corticosteroids, and other active treatments. Five of the seven RCTs found improvements in patient-reported symptoms following laser therapy; however, findings were heterogeneous and not consistently superior to comparator groups. The only sham-controlled trial did not demonstrate superiority of fractional CO₂ laser over sham treatment, suggesting a substantial placebo contribution. Patient satisfaction and adherence were generally higher with laser therapy, and no serious adverse events were reported. CONCLUSIONS: Laser therapies appear promising for VLS management, with favorable safety and patient-reported outcomes. Nevertheless, current evidence is limited by small cohorts and methodological heterogeneity. Larger randomized, sham-controlled trials are required to validate efficacy and long-term safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istanbul University Cerrahpasa - Cerrahpasa Faculty of Medicine, Department of Obtsterics and Gynecology, Turkey. Electronic address: elif.aksahin@istanbul.edu.tr.
- University Medical Center of Johannes Gutenberg University Mainz, Department of Obstetrics and Gynecology, Mainz, Germany.
- Vocational School of Health Services, Bezmialem Vakif University, Turkey.
- Istanbul University Cerrahpasa - Cerrahpasa Faculty of Medicine, Department of Obtsterics and Gynecology, Turkey.
Zitieren
APA
Aksahin, E., Theis, S., Gedik, K. Z., & Erel, C. T. (2026). Energy-based therapies for vulvar lichen sclerosus: A systematic review of randomized controlled trials. Maturitas, 211, 109039. https://doi.org/10.1016/j.maturitas.2026.109039
Vancouver
Aksahin E, Theis S, Gedik KZ, Erel CT. Energy-based therapies for vulvar lichen sclerosus: A systematic review of randomized controlled trials. Maturitas. 2026;211:109039. doi:10.1016/j.maturitas.2026.109039
BibTeX
@article{Aksahin2026,
author = {Aksahin, E and Theis, S and Gedik, K Z and Erel, C T},
title = {Energy-based therapies for vulvar lichen sclerosus: A systematic review of randomized controlled trials},
journal = {Maturitas},
year = {2026},
volume = {211},
pages = {109039},
doi = {10.1016/j.maturitas.2026.109039}
}
EUVIMED